MX2019014054A - Profarmacos de glucuronida de inhibidores de la cinasa janus. - Google Patents
Profarmacos de glucuronida de inhibidores de la cinasa janus.Info
- Publication number
- MX2019014054A MX2019014054A MX2019014054A MX2019014054A MX2019014054A MX 2019014054 A MX2019014054 A MX 2019014054A MX 2019014054 A MX2019014054 A MX 2019014054A MX 2019014054 A MX2019014054 A MX 2019014054A MX 2019014054 A MX2019014054 A MX 2019014054A
- Authority
- MX
- Mexico
- Prior art keywords
- glycuronide
- pro
- drugs
- compounds
- inhibitors
- Prior art date
Links
- 229940002612 prodrug Drugs 0.000 title abstract 2
- 239000000651 prodrug Substances 0.000 title abstract 2
- 108091000080 Phosphotransferase Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 102000020233 phosphotransferase Human genes 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 229940122245 Janus kinase inhibitor Drugs 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 208000018522 Gastrointestinal disease Diseases 0.000 abstract 1
- 229930182480 glucuronide Natural products 0.000 abstract 1
- 150000008134 glucuronides Chemical class 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 239000013067 intermediate product Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/12—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762509847P | 2017-05-23 | 2017-05-23 | |
| PCT/US2018/033818 WO2018217700A1 (en) | 2017-05-23 | 2018-05-22 | Glucuronide prodrugs of janus kinase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2019014054A true MX2019014054A (es) | 2020-02-05 |
Family
ID=62621001
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2019014054A MX2019014054A (es) | 2017-05-23 | 2018-05-22 | Profarmacos de glucuronida de inhibidores de la cinasa janus. |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US10745405B2 (https=) |
| EP (1) | EP3609899A1 (https=) |
| JP (1) | JP2020520955A (https=) |
| KR (1) | KR20200010440A (https=) |
| CN (1) | CN110662747A (https=) |
| AU (1) | AU2018273866B2 (https=) |
| BR (1) | BR112019024509A2 (https=) |
| CA (1) | CA3063963A1 (https=) |
| IL (1) | IL270693A (https=) |
| MX (1) | MX2019014054A (https=) |
| NZ (1) | NZ759764A (https=) |
| PH (1) | PH12019502605A1 (https=) |
| RU (1) | RU2019142472A (https=) |
| WO (1) | WO2018217700A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111094314B (zh) * | 2018-08-15 | 2022-08-12 | 江苏豪森药业集团有限公司 | 含有葡糖苷酸衍生物jak抑制剂的前药及其制备方法和应用 |
| PH12022500002A1 (en) | 2019-06-28 | 2023-04-03 | Kymera Therapeutics Inc | Irak degraders and uses thereof |
| WO2021011868A1 (en) | 2019-07-17 | 2021-01-21 | Kymera Therapeutics, Inc. | Irak degraders and uses thereof |
| WO2021119159A1 (en) | 2019-12-10 | 2021-06-17 | Kymera Therapeutics, Inc. | Irak degraders and uses thereof |
| KR20220145325A (ko) | 2019-12-17 | 2022-10-28 | 카이메라 쎄라퓨틱스 인코포레이티드 | Irak 분해제 및 이의 용도 |
| CN111196831B (zh) * | 2020-01-20 | 2023-05-09 | 山西医科大学 | 一种呋喃酚葡萄糖醛酸结合物的制备方法 |
| CN116867494A (zh) | 2021-02-15 | 2023-10-10 | 凯麦拉医疗公司 | Irak4降解剂和其用途 |
| WO2023018954A1 (en) * | 2021-08-12 | 2023-02-16 | Concert Pharmaceuticals, Inc. | Treatment of jak-inhibition-responsive disorders with prodrugs of jak inhibitors |
| JP2025505812A (ja) * | 2022-02-21 | 2025-02-28 | オンクオリティ ファーマシューティカルズ チャイナ リミテッド | 化合物及びその用途 |
| CN119923257A (zh) * | 2022-04-15 | 2025-05-02 | 密歇根大学董事会 | Jak抑制剂类似物、制剂及其用途 |
| CN115073543B (zh) * | 2022-07-20 | 2022-11-15 | 北京普祺医药科技股份有限公司 | 一种jak抑制剂的化合物前药及其制备与应用 |
| EP4637724A1 (en) | 2022-12-22 | 2025-10-29 | KRKA, d.d., Novo mesto | Veterinary composition comprising oclacitinib |
| WO2024148049A1 (en) * | 2023-01-04 | 2024-07-11 | Kymera Therapeutics, Inc. | Irak4 degraders and uses thereof |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993022334A1 (en) * | 1992-05-04 | 1993-11-11 | Sri International | Pharmaceutical compositions and methods for colonic delivery of corticosteroids |
| US5811388A (en) | 1995-06-07 | 1998-09-22 | Cibus Pharmaceutical, Inc. | Delivery of drugs to the lower GI tract |
| DE60037345T2 (de) | 1999-12-10 | 2008-11-13 | Pfizer Products Inc., Groton | Pyrrolo(2,3-d)pyrimidin-Verbindungen |
| US7798257B2 (en) | 2004-04-30 | 2010-09-21 | Smith International, Inc. | Shaped cutter surface |
| SG10202003901UA (en) | 2005-12-13 | 2020-05-28 | Incyte Holdings Corp | Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors |
| HUE029767T2 (en) | 2008-03-11 | 2017-04-28 | Incyte Holdings Corp | JAK inhibitor azetidine and cyclobutane derivatives |
| KR101335843B1 (ko) | 2008-08-20 | 2013-12-02 | 조에티스 엘엘씨 | 피롤로[2,3-ｄ]피리미딘 화합물 |
| EA021478B1 (ru) * | 2009-10-09 | 2015-06-30 | Инсайт Корпорейшн | ГИДРОКСИЛЬНЫЕ, КЕТО И ГЛЮКУРОНИДНЫЕ ПРОИЗВОДНЫЕ 3-(4-(7Н-ПИРРОЛО[2,3-d]ПИРИМИДИН-4-ИЛ)-1Н-ПИРАЗОЛ-1-ИЛ)-3-ЦИКЛОПЕНТИЛПРОПАННИТРИЛА |
| EP2515913A2 (en) | 2009-12-23 | 2012-10-31 | Glycomyr Inc. | Use of vitamin d glycosides and sulfates for treatment of disease |
| EP2519228A4 (en) | 2009-12-31 | 2013-06-19 | Enzon Pharmaceuticals Inc | POLYMER CONJUGATES FROM AN AROMATIC AMINE WITH COMPOUNDS WITH A CLEANER UREA CONTAINER |
| MX2012009074A (es) | 2010-02-05 | 2012-08-23 | Pfizer | Compuestos de urea pirrolo [2, 3-d] pirimidina como inhibidores de janus quinasa. |
| US20140357557A1 (en) | 2013-05-31 | 2014-12-04 | Cerulean Pharma Inc. | Cyclodextrin-based polymers for therapeutic delivery |
| RS60237B1 (sr) | 2015-11-24 | 2020-06-30 | Theravance Biopharma R&D Ip Llc | Prolekovi jak inhibitornih jedinjenja za lečenje gastorintestinalne inflamatorne bolesti |
| CN106496233B (zh) * | 2016-09-26 | 2018-05-15 | 东南大学 | 吡咯并嘧啶类化合物、其制备方法及其用途 |
-
2018
- 2018-05-22 PH PH1/2019/502605A patent/PH12019502605A1/en unknown
- 2018-05-22 CN CN201880034623.7A patent/CN110662747A/zh active Pending
- 2018-05-22 BR BR112019024509-0A patent/BR112019024509A2/pt not_active Application Discontinuation
- 2018-05-22 WO PCT/US2018/033818 patent/WO2018217700A1/en not_active Ceased
- 2018-05-22 KR KR1020197037814A patent/KR20200010440A/ko not_active Withdrawn
- 2018-05-22 CA CA3063963A patent/CA3063963A1/en not_active Abandoned
- 2018-05-22 JP JP2019564506A patent/JP2020520955A/ja not_active Withdrawn
- 2018-05-22 MX MX2019014054A patent/MX2019014054A/es unknown
- 2018-05-22 NZ NZ759764A patent/NZ759764A/en unknown
- 2018-05-22 EP EP18731628.6A patent/EP3609899A1/en not_active Withdrawn
- 2018-05-22 US US15/986,028 patent/US10745405B2/en not_active Expired - Fee Related
- 2018-05-22 AU AU2018273866A patent/AU2018273866B2/en not_active Expired - Fee Related
- 2018-05-22 RU RU2019142472A patent/RU2019142472A/ru not_active Application Discontinuation
-
2019
- 2019-11-17 IL IL270693A patent/IL270693A/en unknown
-
2020
- 2020-07-13 US US16/926,992 patent/US20210032250A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| RU2019142472A (ru) | 2021-06-24 |
| IL270693A (en) | 2020-01-30 |
| PH12019502605A1 (en) | 2020-10-26 |
| KR20200010440A (ko) | 2020-01-30 |
| JP2020520955A (ja) | 2020-07-16 |
| AU2018273866A1 (en) | 2019-12-19 |
| US10745405B2 (en) | 2020-08-18 |
| CA3063963A1 (en) | 2018-11-29 |
| RU2019142472A3 (https=) | 2021-09-23 |
| EP3609899A1 (en) | 2020-02-19 |
| NZ759764A (en) | 2022-07-01 |
| US20210032250A1 (en) | 2021-02-04 |
| WO2018217700A1 (en) | 2018-11-29 |
| BR112019024509A2 (pt) | 2020-06-23 |
| US20180339990A1 (en) | 2018-11-29 |
| CN110662747A (zh) | 2020-01-07 |
| AU2018273866B2 (en) | 2021-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2019014054A (es) | Profarmacos de glucuronida de inhibidores de la cinasa janus. | |
| CO2018011408A2 (es) | Compuestos de pirimidina como inhibidores de la quinasa jak | |
| CO2017012267A2 (es) | Compuestos de naftiridina como inhibidores de la quinasa jak | |
| CL2018000952A1 (es) | Compuestos útiles como inmunomoduladores | |
| MX2017003695A (es) | Pirimidinonas como inhibidores del factor xia. | |
| MX388751B (es) | Compuestos de imidazo-piperidina fusionada como inhibidores de jak. | |
| DOP2020000083A (es) | Compuesto de pirimidina como inhibidor de las janocinasas | |
| UY35975A (es) | Macrociclos con grupos p2? heterocíclicos como inhibidores del factor xia | |
| EA201691625A1 (ru) | Ароматические гетероциклические соединения как противовоспалительные соединения | |
| BR112015004111A2 (pt) | novos derivados bicíclicos | |
| EA201792021A1 (ru) | Ингибитор jak | |
| UY35467A (es) | Compuestos orgánicos | |
| UY34960A (es) | Dihidropiridona p1 como inhibidores del factor xia | |
| UY34959A (es) | Dihidropiridona p1 como inhibidores del factor xia | |
| CL2019003515A1 (es) | Compuestos heteroaromáticos como inhibidores de vanina. | |
| CL2018001210A1 (es) | Compuestos de criptoficina novedosos y productos conjugados, su preparación y su uso terapéutico. | |
| CY1122381T1 (el) | Παραγωγα ιμιδαζοπυριδαζινης ως αναστολεις pi3kbhta | |
| ECSP19013196A (es) | Derivado de triazolopirazinona útil como un inhibidor de pde1 humana | |
| MA52891A (fr) | Dérivés aza-indoliques utilisés comme inhibiteurs de rho-kinase | |
| IL290181A (en) | Process for the preparation of fluensulfone | |
| MX374813B (es) | Análogos de nucleósidos sustituidos para su uso como inhibidores de prmt5. | |
| EA201892188A1 (ru) | Соединения пирролотриазина в качестве ингибиторов tam | |
| ECSP11010817A (es) | Agentes antifúngicos |